Condensed Balance Sheets (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2012	Dec. 31, 2011
Current Assets:
Cash and cash equivalents	$ 112,986	$ 96,324
Accounts receivable, net of allowance for doubtful accounts of $180,503 in 2012 and $182,880 in 2011	1,069,454	1,154,459
Inventories	589,173	790,494
Advances to contract manufacturer, current	940,318	952,558
Prepaid expenses and other current assets	297,231	304,180
Total current assets	3,009,162	3,298,015
Accounts receivable-long term, net of allowance for doubtful accounts of $332,052 as of March 31, 2012 and $372,000 as of December 31, 2011	230,660	261,256
Advances to contract manufacturer, non current	2,358,107	2,453,948
Investment in distributor, at cost	76,319	76,319
Investment in Medical Joint Venture	46,084	124,179
Furniture, Fixtures & Equipment net of accumulated depreciation of $450,155 as of March 31, 2012 and $446,484 as of December 31, 2011	47,073	52,309
Patents, net of accumulated amortization of $363,159 as of March 31, 2012 and $344,238 as of December 31, 2011	689,587	698,357
Other assets	20,316	27,819
Total assets	6,477,308	6,992,202
Current Liabilities:
Accounts payable	3,407,006	3,931,531
Accrued expenses and other payables	766,259	677,419
Total current liabilities	4,173,265	4,608,950
Long-term Liabilities:
Notes Payable-net of discount of $1,532 and $3,065, respectively	448,468	446,935
Total long-term liabilities	448,468	446,935
Commitments and Contingencies
Stockholders' Equity
Common stock, par value $.001; authorized 50,000,000 shares; 15,693,678 shares issued 1,568,124 shares to be issued and 15,660,345 shares outstanding as of March 31, 2012; 15,556,878 shares issued, 1,501,457 shares to be issued, and 15,523,545 shares outstanding as of December 31, 2011	17,262	17,058
Additional paid-in capital	63,965,072	63,690,837
Accumulated deficit	(61,215,243)	(60,860,062)
Treasury stock, at cost, 33,333 shares	(911,516)	(911,516)
Total stockholders' equity	1,855,575	1,936,317
Total liabilities and stockholders' equity	$ 6,477,308	$ 6,992,202